Valentina Grossi Selected Research

Colorectal Neoplasms (Colorectal Cancer)

4/2023	Colorectal Cancer Chemoprevention: A Dream Coming True?
1/2021	Pharmacological targeting of the novel β-catenin chromatin-associated kinase p38α in colorectal cancer stem cell tumorspheres and organoids.
8/2014	p38α MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance.
3/2014	Targeted therapy against chemoresistant colorectal cancers: Inhibition of p38α modulates the effect of cisplatin in vitro and in vivo through the tumor suppressor FoxO3A.
12/2012	Sorafenib inhibits p38α activity in colorectal cancer cells and synergizes with the DFG-in inhibitor SB202190 to increase apoptotic response.
8/2012	Updates from the Intestinal Front Line: Autophagic Weapons against Inflammation and Cancer.
2/2010	p38alpha is required for ovarian cancer cell metabolism and survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Valentina Grossi Research Topics

Disease

23	Neoplasms (Cancer) 12/2023 - 01/2012
17	Rheumatoid Arthritis 03/2024 - 01/2016
11	Rheumatic Diseases (Rheumatism) 05/2023 - 12/2015
8	COVID-19 02/2023 - 09/2020
7	Colorectal Neoplasms (Colorectal Cancer) 04/2023 - 02/2010
5	Carcinogenesis 12/2023 - 11/2015
5	Autoimmune Diseases (Autoimmune Disease) 05/2023 - 12/2015
5	Psoriatic Arthritis 01/2022 - 04/2016
5	Arthritis (Polyarthritis) 01/2022 - 01/2017
4	Connective Tissue Diseases (Connective Tissue Disease) 05/2023 - 03/2017
4	Inflammation (Inflammations) 05/2023 - 01/2021
4	Infections 11/2021 - 04/2016
4	Ankylosing Spondylitis 01/2020 - 01/2017
2	Adenocarcinoma 12/2023 - 01/2022
2	Breast Neoplasms (Breast Cancer) 11/2023 - 10/2020
2	Vasculitis (Vasculitides) 05/2023 - 01/2022
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2023 - 12/2015
2	Crohn Disease (Crohn's Disease) 01/2023 - 01/2017
2	Pain (Aches) 01/2021 - 01/2017
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2019 - 01/2018
2	Ovarian Neoplasms (Ovarian Cancer) 01/2012 - 02/2010
1	Skin Neoplasms (Skin Cancer) 03/2024
1	Melanoma (Melanoma, Malignant) 03/2024
1	Herpes Zoster 03/2024
1	Galactosemias (Galactosemia) 12/2023
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2023
1	Hereditary Neoplastic Syndromes (Cancer Syndrome, Hereditary) 10/2023
1	Stomach Neoplasms (Stomach Cancer) 10/2023
1	Adult-Onset Still's Disease 05/2023
1	Fibrosis (Cirrhosis) 05/2023
1	Glomerulonephritis 05/2023
1	Systemic Scleroderma (Systemic Sclerosis) 05/2023
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 05/2023
1	Immune System Diseases (Immune Disorders) 04/2023
1	Mood Disorders (Mood Disorder) 01/2021
1	Typhoid Fever (Typhoid) 01/2021
1	Fatigue 01/2021
1	Necrosis 01/2021

Drug/Important Bio-Agent (IBA)

12	AntibodiesIBA 01/2021 - 12/2015
10	Biomarkers (Surrogate Marker)IBA 05/2023 - 04/2016
9	Proteins (Proteins, Gene)FDA Link 05/2023 - 10/2014
6	Leukocyte L1 Antigen Complex (Calgranulin)IBA 05/2023 - 01/2017
3	Janus Kinase InhibitorsIBA 03/2024 - 01/2022
3	CateninsIBA 12/2023 - 01/2021
3	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 03/2019
3	Urokinase Plasminogen Activator ReceptorsIBA 04/2023 - 01/2022
3	Etanercept (Enbrel)FDA Link 01/2023 - 01/2018
3	tocilizumab (atlizumab)FDA Link 01/2020 - 01/2016
3	Abatacept (Orencia)FDA Link 01/2019 - 04/2016
2	tofacitinibIBA 03/2024 - 01/2022
2	Rheumatoid FactorIBA 12/2023 - 01/2021
2	mRNA VaccinesIBA 09/2023 - 12/2022
2	Antirheumatic Agents (DMARD)IBA 02/2023 - 01/2016
2	AutoantibodiesIBA 01/2023 - 07/2018
2	Messenger RNA (mRNA)IBA 12/2022 - 01/2022
2	COVID-19 VaccinesIBA 12/2022 - 12/2021
2	Biosimilar PharmaceuticalsIBA 07/2022 - 01/2017
2	VaccinesIBA 01/2022 - 12/2021
2	BNT162 VaccineIBA 01/2022 - 12/2021
2	Neutralizing AntibodiesIBA 01/2022 - 12/2021
2	Rituximab (Mabthera)FDA Link 01/2021 - 08/2020
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2018
2	Immunoglobulin M (IgM)IBA 01/2021 - 09/2020
2	Immunoglobulin A (IgA)IBA 01/2021 - 01/2021
2	Immunoglobulin G (IgG)IBA 09/2020 - 01/2017
2	Infliximab (Remicade)FDA Link 01/2018 - 01/2017
1	upadacitinibIBA 03/2024
1	GLPG0634IBA 03/2024
1	baricitinibIBA 03/2024
1	galactose-1-phosphateIBA 12/2023
1	ZinostatinIBA 11/2023
1	A-Form DNA (A-DNA)IBA 10/2023
1	Epithelial Cell Adhesion MoleculeIBA 10/2023
1	Histones (Histone)IBA 10/2023
1	Calgranulin AIBA 05/2023
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2023
1	CytokinesIBA 04/2023
1	ametantrone (HAQ)IBA 01/2023
1	N-phthaloylglutamic acidIBA 01/2023
1	Histone-Lysine N-MethyltransferaseIBA 01/2023
1	Cadherins (E-Cadherin)IBA 12/2022
1	MethyltransferasesIBA 12/2022
1	Cyclin-Dependent Kinase 2IBA 12/2022
1	Fibronectins (Fibronectin)IBA 12/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 12/2022
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 12/2022
1	crenigacestatIBA 02/2022
1	ProteomeIBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 11/2021

Therapy/Procedure

12	Therapeutics 01/2022 - 01/2012
3	Precision Medicine 12/2023 - 12/2022
3	Drug Therapy (Chemotherapy) 01/2018 - 02/2010
2	Biological Therapy 04/2020 - 04/2016
1	Aftercare (After-Treatment) 03/2024
1	Radiotherapy 09/2023
1	Chemoprevention 04/2023
1	Cannula 01/2022
1	Activities of Daily Living (ADL) 01/2021